Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10511787rdf:typepubmed:Citationlld:pubmed
pubmed-article:10511787lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10511787lifeskim:mentionsumls-concept:C0337910lld:lifeskim
pubmed-article:10511787lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:10511787lifeskim:mentionsumls-concept:C0085504lld:lifeskim
pubmed-article:10511787lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:10511787lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:10511787pubmed:issue8lld:pubmed
pubmed-article:10511787pubmed:dateCreated1999-10-26lld:pubmed
pubmed-article:10511787pubmed:abstractTextBlood samples were obtained from 243 consecutive coronary artery disease (CAD) patients (177 male, 66 female) aged 35-78 years (mean, 61 years) admitted for coronary angiography because of suspected coronary heart disease, and from 115 blood donors (91 male, 24 female) aged 25-60 years (mean, 47 years). Of the 243 CAD patients, 179 (74%) were positive by an ELISA method for Chlamydia pneumoniae antibodies IgG and 132 (54%) were positive for C. pneumoniae IgA. Among the 115 blood donors, 80 (70%) were positive for C. pneumoniae IgG and 49 (43%) were positive for C. pneumoniae IgA. When IgG antibodies were considered, there was no significant difference between CAD patients and healthy controls (OR = 1.29, 95% CI = 0.79-2.10, p > 0.05). In cases of positive IgA antibodies alone, there was a significant difference between CAD patients and healthy controls (OR = 1.58, 95% CI = 1.01-2.4, p = 0.029). If both IgG and IgA antibodies were positive, OR was increased from 1.58 to 1.80 (95% CI = 0.97-3.36, p = 0.044). In conclusion, C. pneumoniae infection is common in Thai people but chronic C. pneumoniae infection is more common in CAD patients than in middle-aged blood donors.lld:pubmed
pubmed-article:10511787pubmed:languageenglld:pubmed
pubmed-article:10511787pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10511787pubmed:citationSubsetIMlld:pubmed
pubmed-article:10511787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10511787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10511787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10511787pubmed:statusMEDLINElld:pubmed
pubmed-article:10511787pubmed:monthAuglld:pubmed
pubmed-article:10511787pubmed:issn0125-2208lld:pubmed
pubmed-article:10511787pubmed:authorpubmed-author:LeelarasameeA...lld:pubmed
pubmed-article:10511787pubmed:authorpubmed-author:LeowattanaWWlld:pubmed
pubmed-article:10511787pubmed:authorpubmed-author:MahanondaNNlld:pubmed
pubmed-article:10511787pubmed:authorpubmed-author:BhuripunyoKKlld:pubmed
pubmed-article:10511787pubmed:authorpubmed-author:PokumSSlld:pubmed
pubmed-article:10511787pubmed:authorpubmed-author:SuwimolBBlld:pubmed
pubmed-article:10511787pubmed:issnTypePrintlld:pubmed
pubmed-article:10511787pubmed:volume82lld:pubmed
pubmed-article:10511787pubmed:ownerNLMlld:pubmed
pubmed-article:10511787pubmed:authorsCompleteYlld:pubmed
pubmed-article:10511787pubmed:pagination792-7lld:pubmed
pubmed-article:10511787pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:meshHeadingpubmed-meshheading:10511787...lld:pubmed
pubmed-article:10511787pubmed:year1999lld:pubmed
pubmed-article:10511787pubmed:articleTitleThe prevalence of Chlamydia pneumoniae antibodies in Thai patients with coronary artery disease.lld:pubmed
pubmed-article:10511787pubmed:affiliationDepartment of Clinical Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.lld:pubmed
pubmed-article:10511787pubmed:publicationTypeJournal Articlelld:pubmed